bioRxiv / medRxiv
open access
CC BY 4.0
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseases.#145791
- Astrocytes as Therapeutic Targets in Neurodegenerative Disorders#1146122
- Identifying Blood Proteomic Markers of Parkinson's Disease Dementia Using High-Throughput Approaches#438521
- A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia.#218937
- Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS#893260
Record · ID 390886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive